Data last revised on 09 May 2025  
Patent data
(11)Registration Number:P20250199  (Validated european patent)
(10) HR P20250199 T1
 1st pg.Desc.
(21) File number: P20250199T
(22) Date of filing the request: 17.02.2025
(45) Patent Publication Date and Gazette Number:11.04.2025
(54) English Title:BISPECIFIC ANTI-BCMA X ANTI-CD3 ANTIBODIES AND USES THEREOF
(96) Number of the European patent application:EP 19749096.4, 18.07.2019 
(97) Publication data of the European patent application:EP 3823664, 26.05.2021, 202121, en 
(97) Publication data of the European patent:EP 3823664, 08.01.2025, 202502, en 
(51) IPC: A61K 39/00 (2006.01)
  A61P 35/02 (2006.01)
  C07K 16/28 (2006.01)
(73) Holder(s):
1.Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591-6707, US
 
(72) Inventor(s):
1.Eric Smith, New York, 10591, US
 
 
2.Kara Olson, New York, 10591, US
 
 
3.Frank Delfino, New York, 10591, US
 
 
4.David Dilillo, New York, 10591, US
 
 
5.Jessica Kirshner, New York, 10591, US
 
 
6.Olga Sineshchekova, New York, 10591, US
 
 
7.Qian Zhang, New York, 10591, US
 
(74) Representative:Odvjetnik Tomislav Hadžija, u suradnji sa DENNEMEYER & ASSOCIATES,
BCI- Business Center International - 1. kat, Miramarska cesta 24, 10000 Zagreb, HR
(30) Priority Data:
(31) 201962793645 P (32) 17.01.2019 (33) US
 201862750968 P  26.10.2018  US
 201862700596 P  19.07.2018  US
(86) PCT Application Number and DatePCT/US2019042447; 18.07.2019
(87) PCT Publication Number and DateWO2020018820; 23.01.2020
(46) Publication Date of Translation of a European Patent Claims and the Gazette Number:11.04.2025
 

Disclaimer
The State Intellectual Property Office assumes no responsibility for consequences arising from the use of the data contained in this site.

Small logo © State Intellectual Property Office of the Republic of Croatia